STP-503

N/A

Report date: 2022/02/08 11:21:07

NME

Base Information

Drug NameSTP-503

Drug Alias NameN/A

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA

Mechanisms of ActionRNA interferenceTransforming growth factor beta 1 inhibitors

TargetsTransforming growth factor beta 1

Therapy Area/IndicationsProstatic NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSirnaomics

China Registration ClassN/A

Active CompaniesSirnaomics

Inactive CompaniesN/A

Active IndicationsProstatic NeoplasmsBreast Neoplasms

Inactive IndicationsN/A

ATC CodeN/A